Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Non-randomized Study of DOXIL Consolidation Treatment for Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneal Carcinoma.

NCT00248248 is registered in ClinicalTrials.gov with Southeastern Gynecologic Oncology as lead sponsor.

NCT NCT00248248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00248248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Non-randomized Study of DOXIL Consolidation Treatment for Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneal Carcinoma.
Lead sponsor
Southeastern Gynecologic Oncology
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2005
Completion date
October 31, 2011
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian neoplasm